ClinicalTrials.gov record
Terminated Phase 3 Interventional

Study to Assess LX201 for Prevention of Corneal Allograft Rejection or Graft Failure in Subjects Who Have Experienced One or More Rejection Episodes Following Penetrating Keratoplasty

ClinicalTrials.gov ID: NCT00447642

Public ClinicalTrials.gov record NCT00447642. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 5:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center, Placebo-Controlled, Randomized, Parallel-Group, Dose-Ranging Study to Assess the Efficacy and Safety of LX201 Implantation for the Prevention of Corneal Allograft Rejection Episodes or Graft Failure in Subjects Who Have Experienced One or More Rejection Episodes Following Penetrating Keratoplasty

Study identification

NCT ID
NCT00447642
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Lux Biosciences, Inc.
Industry
Enrollment
122 participants

Conditions and interventions

Interventions

  • LX201 Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2007
Primary completion
Jul 31, 2008
Completion
Dec 31, 2009
Last update posted
Oct 10, 2012

2007 – 2010

United States locations

U.S. sites
24
U.S. states
18
U.S. cities
22
Facility City State ZIP Site status
Cornea Consultants of Arizona Phoenix Arizona 85032
Loma Linda University Health Care Loma Linda California 92354
USC Doheny Eye Institute Los Angeles California 90033
Bascom Palmer Eye Institute Miami Florida 33136
Emory Eye Center Atlanta Georgia 30322
University of Illinois at Chicago Chicago Illinois 60612
Price Vision Group Indianapolis Indiana 46260
The Eye Center at Union Memorial Hospital Baltimore Maryland 21218
Wilmer Eye Institute, Cornea Service Baltimore Maryland 21287
New England Eye Center Boston Massachusetts 02111
W.K. Kellogg Eye Center - University of Michigan Ann Arbor Michigan 48105
MN Eye Consultants, P.A. Bloomington Minnesota 55431
Tauber Eye Center Kansas City Missouri 64111
Ophthalmology Associates St Louis Missouri 63141
UMDNJ - New Jersey Medical School Institute of Ophthalmology and Visual Science Newark New Jersey 07103
New York Eye and Ear Infirmary New York New York 10003
Mount Sinai School of Medicine New York New York 10029
Ophthalmic Consultants of Long Island Rockville Centre New York 11570
Cornea Consultants of Albany Slingerlands New York 12159
Duke University Eye Center Durham North Carolina 27705
University Hospitals Case Medical Center Cleveland Ohio 44106
Cornea Associates of Texas Dallas Texas 75231
Virginia Eye Consultants Norfolk Virginia 23502
Eye Associates NW Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00447642, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 10, 2012 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00447642 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →